Company news

Island Pharmaceuticals Ltd news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Island submits responses to FDA questions for ISLA-101

April 16, 2023

ILA receives additional FDA feedback on IND for ISLA 101

January 31, 2023

Island receives FDA feedback on Phase 2a clinical study

January 19, 2023

ILA submits IND to US FDA for Phase 2a PEACH clinical trial

December 27, 2022

IRB approval received for ISLA101 Phase 2a clinical trial

December 14, 2022

ISLA101 drug product achieves stability milestone

December 14, 2022

ILA granted key Canadian patent for ISLA-101

November 15, 2022

Positive analytical results for ISLA-101 capsules

November 13, 2022

ISLA-101 manufacturing progress

October 27, 2022

ISLA-101 manufacturing and timeline update

June 15, 2022

Island executes PEACH clinical study CRO agreement

January 3, 2022

ISLA-101 Phase 2a clinical trial update

November 8, 2021

Island updates API agreement

September 20, 2021

Griffith Uni Anti-Viral Molecule Screening Collaboration

August 22, 2021

Island granted key Australian patent for ISLA-101

August 17, 2021

Island secures API - shortens timeline to clinical trials

July 22, 2021

Island Pharmaceuticals granted key United States patent

May 18, 2021

← Newer news releases

Decks

The 5 newest of 36 decks. Every deck is listed under its year.